Cofoe Medical sets H-share offer price at HK$39.33 ahead of 6 May Main Board debut

Bulletin Express05-04

Cofoe Medical Technology Co., Ltd. has fixed the offer price for its Hong Kong H-share listing at HK$39.33 per share, exclusive of standard levies and brokerage fees.

According to the prospectus, final details on subscription levels for both the International Offering and the Hong Kong Public Offering, as well as the allocation results, are scheduled for release on 5 May 2026. Subject to the Global Offering becoming unconditional by 8:00 a.m. that day, trading in Cofoe Medical’s H Shares is expected to commence on the Main Board of the Stock Exchange of Hong Kong at 9:00 a.m. on 6 May 2026. Shares will trade in board lots of 100.

The company has appointed Mr Zhang Min as Executive Director and Chairman, with three additional executive directors and three independent non-executive directors on the board.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment